Literature DB >> 19351962

The role of matrix metalloproteinases in the pathogenesis of endometriosis.

Miltiadis Pitsos1, Nikolaos Kanakas.   

Abstract

Endometriosis is a benign, estrogen-dependent disease with an obscure etiology. Even the most widely accepted theory of retrograde menstruation cannot satisfactorily explain the development of endometriosis due to the many gaps in our understanding of its pathophysiology. Although most women have retrograde menstruation; only some develop endometriosis. Apart from simply being present in the peritoneal cavity, the endometrial cells are able to attach to, invade the peritoneum, and proliferate to create and maintain an endometriotic lesion. Matrix metalloproteinases (MMPs) are a group of enzymes that degrade the extracellular matrix. These enzymes participate in the histologic changes of the endometrium during the menstrual cycle with generally a higher expression during the menstrual and proliferative phase of the endometrium and a decreased expression during the secretory phase. As noted above, not only do these enzymes play a crucial factor in the cycling endometrium but the degradation of extracellular matrix is essential for the endometrial cells to invade the peritoneum and to develop an endometriotic lesion as well. The aim of this review is to describe the altered expression of MMPs in the development of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351962     DOI: 10.1177/1933719109333661

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  16 in total

Review 1.  Extracellular matrix dynamics and fetal membrane rupture.

Authors:  Jerome F Strauss
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

2.  Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model.

Authors:  Umit Goktolga; Sabri Cavkaytar; Sadiman Kiykac Altinbas; Omer Lutfi Tapisiz; Anil Tapisiz; Ozlem Erdem
Journal:  Exp Ther Med       Date:  2015-02-19       Impact factor: 2.447

Review 3.  Nanomedicines for Endometriosis: Lessons Learned from Cancer Research.

Authors:  Abraham S Moses; Ananiya A Demessie; Olena Taratula; Tetiana Korzun; Ov D Slayden; Oleh Taratula
Journal:  Small       Date:  2021-01-25       Impact factor: 13.281

4.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.

Authors:  JeHoon Lee; Sakhila K Banu; Robert C Burghardt; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Biol Reprod       Date:  2013-03-28       Impact factor: 4.285

Review 5.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

6.  Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.

Authors:  Outi Uimari; Nilufer Rahmioglu; Dale R Nyholt; Katy Vincent; Stacey A Missmer; Christian Becker; Andrew P Morris; Grant W Montgomery; Krina T Zondervan
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

7.  Identification of global transcriptome abnormalities and potential biomarkers in eutopic endometria of women with endometriosis: A preliminary study.

Authors:  Luyang Zhao; Chenglei Gu; Mingxia Ye; Zhe Zhang; Weidong Han; Wensheng Fan; Yuanguang Meng
Journal:  Biomed Rep       Date:  2017-05-03

8.  The Effect of Imbalanced Progesterone Receptor-A/-B Ratio on Gelatinase Expressions in Endometriosis.

Authors:  Sepideh Mousazadeh; Azadeh Ghaheri; Maryam Shahhoseini; Reza Aflatoonian; Parvaneh Afsharian
Journal:  Int J Fertil Steril       Date:  2019-04-27

9.  Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells.

Authors:  Pietro G Signorile; Francesca Petraglia; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2014-05-29

Review 10.  Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?

Authors:  David A Hart
Journal:  Int J Inflam       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.